Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Ophthalmology. 2019 Mar 21;126(10):1350–1355. doi: 10.1016/j.ophtha.2019.03.019

Table 2.

Ophthalmologic conditions marketed by “cell therapy” clinics.

Marketed Condition Number of Businesses
Macular degeneration 35
Optic neuritis 18
Retinitis pigmentosa 17
Diabetic retinopathy 16
Glaucoma 14
Optic neuropathy* 13
Retinal detachment 8
Dry eye 7
Stargardt’s macular dystrophy 4
Retinal degeneration 3
Macular hole 2
Blindness 2
Central retinal vein occlusion/retinal vascular occlusion 3
Plaquenil toxicity 2
Corneal diseases 2
Limbal stem cell deficiency 2
Corneal ulcers 2
Retinal micro hemorrhage 1
Myopic macular degeneration 1
Ischemic retinopathy 1
Retinitis 1
Ophthalmology 1
Stevens-Johnson syndrome 1
Trauma 1
*

Optic neuropathy includes optic nerve atrophy, Leber’s hereditary optic neuropathy, and optic nerve injury.